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Methods — This study was performed in 169 French males over 
60 years. Aortic stiffness was assessed by carotid/femoral pulse 
wave velocity (PWV). BMD and body composition were determined 
with a DEXA device in lumbar spine L1-L4, femoral neck and total 
body.
Results — Lean mass was positively correlated with the three 
T-scores accounting for 11.6 %, 26.6 % and 12.2 % of the variability 
in lumbar spine L1-L4, femoral neck and total body BMD T-scores 
respectively. Fat mass had no effect on BMD. However, fat mass 
was positively correlated with aortic PWV accounting for 9.8 % of its 
variability. Lean mass was not a determinant of PWV. Hypertension, 
diabetes and dyslipidemia were associated with higher PWV but 
had no effect on BMD.
Conclusions — In males from a general population over 60 years of 
age, bone and arterial aging are differently in uenced by lean and 
fat mass. Our results indicate that elderly men with high lean mass 
and low fat mass exhibit the best arterial and bone pro le, with 
the lowest arterial stiffness and the highest BMD.
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THE REGULATION OF LARGE ARTERY STIFFNESS 
BY THE VASCULAR ENDOTHELIUM INCLUDES THE 
CONTROL OF ARTERIAL WALL VISCOSITY
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Although the viscoelasticity of large arteries has been extensively 
investigated, few studies have focused on arterial wall viscosity 
(AWV) itself and its regulation by the endothelium in vivo. This 
is of particular importance since AWV is a major source of energy 
dissipation through the vascular system reducing the ef ciency of 
cardiovascular coupling.
We simultaneously measured in 8 healthy volunteers (age: 22±1 
years) radial artery diameter and arterial pressure (NIUS02) 
before and after 8 min local infusion of L-NMMA (8 mmol/min) 
as NO-synthase inhibitor, tetraethylammonium (TEA: 9 mmol/
min), as blocker of calcium-activated potassium channels, the 
target of endothelium-derived hyperpolarizing factors (EDHF), 
and L-NMMA+TEA. Arterial pressure and diameter were carefully 
synchronized and the pressure-diameter relationship were 
constructed at each cardiac cycle. AWV was estimated from the 
ratio of the area of the hysteresis loop of the pressure-diameter 
relationship to the area representing the whole energy exchanged 
during each cardiac cycle ( gure). Radial artery stiffness was 
evaluated during the whole cardiac cycle by the calculation of 
cross-sectional distensibility and during the ventricular ejection 
period by the slope of the ascending loop.
L-NMMA did not modify signi cantly arterial distensibility and 
ascending slope but, paradoxically reduced AWV (from 29.5±0.7 to 
24.9±0.7 %, P=0.05). Conversely, TEA reduced arterial distensibility 
(from 6.50±0.19 to 5.53±0.2 10-5.kPa, P=0.002) and the ascending 
slope (from 1.03±0.01 to 0.86±0.03 mm.mmHg, P<0.001) and 
increased AWV (from 29.1±0.5 to 35.0±0.7 %, P=0.04). The 
combination of L-NMMA+TEA induced a more marked decrease 
in distensibility (from 6.86±0.24 to 4.85±0.17 10-5.kPa, P<0.001) 
and ascending slope (from 1.06±0.04 to 0.69±0.03 mm.mmHg, 
P<0.001) and increase in AWV (from 29.0±0.9 to 43.0±0.7, P=0.04) 
as compared with TEA alone (all P<0.05).
These results demonstrate in vivo in humans that the vascular 
endothelium contributes, in addition to large artery elasticity, to 
the regulation of AWV through the release of NO and EDHF.
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The old spontaneously hypertensive rat (SHR) is known to be a good 
experimental model that is highly analogous to essential hypertension 
in man but is costly and time consuming. Chronic inhibition of nitric 
oxide (NO) production in young adult SHR is an experimental model of 
malignant hypertension and chronic renal disease, very similar to old 
SHR¹. Considering that acute or chronic decreases in NO production 
in normotensive rats increase arterial stiffness, we aimed to compare 
the aortic stiffness between SHR/L-NAME and old SHR.
Male SHR (18 weeks old) received N-Nitro-L-Arginine Methyl Ester 
(L-NAME) 6 mg/kg/d in drinking water (SHR/L-NAME) for 2 weeks 
and were compared to SHR and Wistar Kyoto rats (WKY). Moreover, 
two groups are composed of 55 weeks aged SHR (Old SHR) and WKY 
(Old WKY). Under anesthesia, two catheters were introduced in the 
left common carotid artery and the left femoral artery to measure 
central and peripheral blood pressure and assess aortic stiffness 
with pulse wave velocity (PWV= distance between the tips of the 
two catheters / transit time), β-index (2.11x(PWV²/Diastolic blood 
pressure)), ampli cation and pulse pressure (PP).
At 20 weeks, although SHR have higher central systolic blood 
pressure (SBP) than WKY (201±7 mmHg vs. 154±4 mmHg), no 
signi cant difference in PWV, PP, ampli cation and β-index was 
observed between these two groups. With age, old WKY have 
higher SBP (181±8 mmHg) and higher PWV (6.7±0.5 m/s) and β-index 
(0.70±0.08) than young WKY. Old SHR exhibit higher SBP (252±13 
mmHg), PWV (9.3±0.7 m/s), PP (71±7 mmHg), β-index (1.08±0.16) 
than old WKY and young SHR (PWV=6.3±0.2 m/s, PP=39±3 mmHg 
and β-index=0.50±0.03). Young SHR, after 2 weeks of L-NAME 
administration, have higher SBP (238±10 mmHg) and aortic stiffness 
(PWV=8.6±0.6 m/s, PP=54±6 mmHg and β-index=0.89±0.14) than 
young SHR and possess the aortic stiffness observed in old SHR.
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In conclusion, our results indicate a close analogy in arterial stiffness 
between SHR/L-NAME and old SHR. Thus, this experimental model 
shows similarities to hypertensive humans and appears relevant to 
test new anti-hypertensive treatments.
¹ Zhou X, Frohlich ED. Medicinal Chemistry. 2007 ; 3:61-65.
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Purpose — Fabry disease is a de ciency of lysosomal enzyme 
α-galactosidase A leading to accumulation of glycosphyngolipids 
in cardiac and vascular tissues. Although enzyme replacement 
therapy decreases glycosphingolipids storage in tissues, we have 
described a continuous vascular hypertrophy whereas the aortic 
stiffness was paradoxically decreasing under long-term enzyme 
therapy. Preliminary results reported that Fabry’s aorta diameters 
under treatment were more dilated in comparison to control 
group. The objective of this study is to determined parallelism 
between presumed aorta dilatation, aortic stiffness and arterial 
remodeling in treated Fabry patients.
Methods — 41 treated patients were enrolled (38±12 yrs) with arterial 
measurements of a) radial and carotid intima-media thickness, 
diameter, local pulse pressure and distensibility obtained with 
echotracking device ; b) aortic stiffness obtained through carotid to 
femoral pulse wave velocity with tonometry and c) aorta diameters 
(sinus, ascending and descending tubule, arch aortic) assessed by 
magnetic resonance imaging examinations.
Results — Pulse wave velocity was positively correlated with 
ascending and descending aorta tubules diameters in univariate 
analysis (respectively R²=0.13, P< 0.05 ; R²=0.11, P<0.05) and 
after adjustment on body surface area, pulse pressures ratio and 
hypertension (respectively P<0.05 and P=0.01). Aorta diameters 
(ascending, descending tubule and arch aortic) were positively 
correlated with carotid diameter (respectively R²=0.44, P<0.0001, 
R²=0.32, P=0.0001 and R²=0.34, P=0.0001) and after adjustment 
as previously (respectively P=0.0001, P<0.05 and P<0.001). 
No correlations were found among all aorta diameters and 
radial diameter and between aorta sinus and carotid and radial 
artery properties. Carotid stiffness was positively correlated 
with ascending, descending tubules and arch aortic diameters 
(respectively R²=0.38, P<0.0001 ; R²=0.29, P<0.0005 and R²=0.23 
P<0.005) and after adjustments as previously adding pulse wave 
velocity (P<0.0001, P<0.0005 and P<0.01).
Conclusion — this study underlies interrelation between aortic 
diameters, aortic stiffness, elastic and muscular arteries geometry 
and carotid stiffness in patients with Fabry disease under enzyme 
therapy.
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L’EFFET PRÉVENTIF DU TRAITEMENT 
ANTIHYPERTENSEUR SUR LES ACCIDENTS 
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VARIE AU COURS DU TEMPS ET SELON LA NATURE 
DU TRAITEMENT
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Introduction — La base INDANA est une méta-analyse de données 
de patients hypertendus issus d’études comparant le traitement 
antihypertenseur (TH), diurétique ou bêtabloquant, au placebo. 
Des analyses précédentes ont montré que l’effet préventif du TH, 
sans prise en compte de sa nature, sur les accidents coronariens 
(AC) et sur les accidents vasculaires cérébraux (AVC) variait dans 
le temps. L’effet du TH sur le risque d’AC est immédiat et diminue 
ensuite au cours du temps, alors que l’effet sur le risque d’AVC 
se renforce au cours du temps. Dans ce travail nous avons étendu 
l’analyse de la variation de l’effet dans le temps en prenant en 
compte la nature du TH de première intention : diurétique ou 
bêtabloquant.
Méthode — Nous avons considéré les études ayant utilisé en 
première intention un traitement diurétique (20 782 patients), ou 
bêtabloquant (17 225 patients). Les critères de jugement étaient les 
AVC et les AC. Nous avons découpé les 5 premières années de suivi 
en intervalles d’un an et utilisé un modèle de Poisson multivarié 
avec un ajustement sur le TH, le temps, l’age, le sexe, l’étude, 
ainsi que les interactions d’intérêt.
Résultats — L’effet des diurétiques sur les AVC apparaît au cours de 
la deuxième année et augmente au cours du temps (interaction non 
signi cative, HR = 0.89 [0.78 — 1.02]), sans différence entre les 
sexes. L’effet des bêtabloquants apparaît au cours de la 3e année 
et augmente au cours du temps (interaction signi cative, HR = 0.81 
[0.7 — 0.94]), sans différence entre les sexes. L’effet des diurétiques 
sur les AC est signi catif (HR = 0.81 [0.70-0.94]) sans interaction 
avec le temps ou avec le sexe. L’effet des bêtabloquants diminue 
dans le temps (interaction non signi cative, HR = 1.12 [1 — 1.26]) 
avec un effet délétère non signi catif chez les femmes.
Conclusion — La dynamique de prévention du TH est différente sur 
les AC et les AVC. Concernant les AVC, diurétiques et bêtabloquants 
ont un pro l d’action dans le temps très proche. Concernant les AC, 
la diminution de l’effet protecteur dans le temps semble être liée 
aux bêtabloquants qui seraient moins protecteurs, en particulier 
chez les femmes.
